**Pieris Pharmaceuticals Announces Results of 2024 Annual Meeting and Updates on Merger Agreement**On December 2, 2024, Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) held its annual meeting of stockholders where significant decisions were made. A quoru

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Pieris Pharmaceuticals’s 8K filing here. About Pieris Pharmaceuticals (Get Free Report) Pieris Pharmaceuticals, Inc, a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics […]

Leave a Reply

Your email address will not be published.

Previous post Chartwell Retirement Residences (OTCMKTS:CWSRF) Short Interest Update
Next post Ford Motor (NYSE:F) Trading Down 0.7% – Here’s What Happened